CUV 3.92% $15.65 clinuvel pharmaceuticals limited

Ann: Chair Letter to Shareholders, page-22

  1. 310 Posts.
    lightbulb Created with Sketch. 13
    Feeling even more certain the valuation has no basis in reality.

    I love how you've intellectually proven my points wrong.
    Well currently it's unit cost is 55k to 85k euro... & reimbursement has been turned down by quite a few governments & insurers. With 4 doses a year, I can see why.

    Last edited by wg159: 09/05/19
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.